Active Biotech AB (publ) (LON:0GQU)

Market Cap	8.32M
Revenue (ttm)	n/a
Net Income (ttm)	-2.84M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,852
Average Volume	41,007
Open	0.0990
Previous Close	n/a
Day's Range	0.0990 - 0.0990
52-Week Range	0.0080 - 0.0090
Beta	0.49
RSI	42.91
Earnings Date	May 8, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company was incorporated in 198...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 6
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GQU

Financial Performance

Financial numbers in SEK